SCHEMBL16201366

SCHEMBL16201366

CCCN(C)Cc1c[nH]nc1-c1ccc(C(F)(F)F)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 3/20 0.36
PRMT8 Q9NR22 2/20 0.36
PRMT3 O60678 1/20 0.34
CARM1 Q86X55 1/20 0.34
PRMT1 Q99873 1/20 0.34
KMO O15229 2/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
SCN9A Q15858 1/20 0.32
PYCR1 P32322 1/20 0.32
FAAH O00519 2/20 0.32
GRM2 Q14416 2/20 0.31
NOTUM Q6P988 2/20 0.31
TRPV3 Q8NET8 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
AR P10275 1/20 0.31
DAO P14920 1/20 0.31
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16125841 0.91 NOTUM (0.41) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16201208 0.91 PRMT6 (0.45) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16201418 0.87 PRMT6 (0.39) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16201375 0.86 NISCH (0.36) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16125846 0.85 MPL (0.39) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16201386 0.85 ALDH1A1 (0.35) PRMT6PRMT8PRMT1
SCHEMBL16201378 0.84 PIM1 (0.33) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16201390 0.84 PRMT6 (0.39) PRMT6PRMT8PRMT1KMO
SCHEMBL16125376 0.82 PRMT3 (0.31) PRMT6PRMT8PRMT3CARM1PRMT1
SCHEMBL16125827 0.82 PRMT6 (0.45) PRMT6PRMT8PRMT3CARM1PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9776972-B2 Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof EPIZYME INC. (US) 2017-10-03 US disclosed
US-9346761-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2016-05-24 US disclosed
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-05-19 US disclosed
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323537-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT6 4/4885PRMT8 6/4885PRMT3 2/4885
US-20160137609-A1 PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT6 5/4885PRMT8 6/4885PRMT3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.